For enquiries relating to the submission of articles or to articles currently being reviewed, please contact the Journal’s editorial office at jacchf@acc.org. For information on articles that have been accepted for publication, please visit Elsevier’s Authors Home at https://www.elsevier.com/au...
Heart Failure editorial staff atjacchf@acc.org. At initial submission, a manuscript is reviewed by editorial staff for compliance with journal style and to make sure the submission is clear and legible for reviewers and editors. Once the editorial staff have checked in the paper, it is assigned...
While the JACC: Heart Failure Associate Editor will be identified at the end of the review process, all correspondence concerning a manuscript should be addressed to the JACC: Heart Failure editorial staff at jacchf@acc.org. At initial submission, a manuscript is reviewed by editorial staff for...
The study was supported by Novartis. Novartis participated in the design and conduct of the PARAGON-HF trial; collection, management, and interpretation of the data; and reviewed and commented on the manuscript before submission ...
The FDA encourages submission of PPI and provides guidance on the conduct of PPI studies. PPI is most relevant in decisions that are “preference sensitive” as in the case of AS. Preference sensitive decisions are when: 1) there is more than 1 valid treatment option; 2) data supporting ...